The global market for newborn screening is anticipated to grow at a CAGR of 13.76% over the forecast duration of 2019-2027.
Due to the rise in the pervasiveness of congenital diseases, a large number of newborns are being affected by such conditions, which is a major driver for the newborn screening market. Moreover, government backing for newborn child health and the rising awareness for congenital heart disease in newborns are further pushing the growth of the market significantly.
The increase in the global fertility rate has proven to be beneficial for the growth of the market. Furthermore, newborn screening helps in the early identification and management of affected newborns. Technological advancements in newborn screening and increase in the number of pregnant women with advanced maternal age can be used as opportunities for the growth of the market.
On the flip side, the absence of proper healthcare infrastructure for newborn babies in developing countries and the socio-economic hurdles in the implementation of newborn child screening act as major restraints for the growth of the market. Furthermore, the dearth of skilled professionals in the healthcare industry and maintenance issues of hospital equipment severely limit the growth of the newborn screening market.
The global newborn screening market spans across five major regions, namely, Latin America, Europe, North America, Asia-Pacific and the Middle East and Africa.
The Asia-Pacific newborn screening market is the leading market globally, with the highest CAGR. In addition, North America's supportive policies further supplement the growth of the newborn screening market in the US and Canada. For instance, the United States Government has mandated the newborn hearing screening among all the territories and 50 states of the United States since 1996, as per the Journal of Early Hearing Detection and Intervention (JEHDI), 2016 research.
Further, in 2011, the US Department of Health and Human Services (HHS) added critical congenital heart defects (CCHD) in the Recommended Uniform Screening Panel for all the newborns born in the US. Further, high healthcare and R&D expenditure in the US and Canada also act as drivers for the growth of the newborn screening market in North America.
The dominant companies in the market are Trivitron Healthcare, ZenTech S.A., Masimo Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., SCIEX, Bio-Rad Laboratories, Inc., BioTek Instruments, Inc., Waters Corporation, Thermo Fisher Scientific, Inc., Cardinal Health, Inc., NeoGen Labs Pvt. Ltd., Medtronic Plc, Natus Medical, Incorporated and GE Healthcare Limited.
BioTek Instruments, Inc., is a medical device company that develops, manufactures and distributes microplate instrumentation and software. The company's products include detection, liquid handling, robotics, software and robotics and accessories.
It provides accessories such as BioStack integration kits, bottles and tubing, cables, cassettes, dispense or waste systems, filter accessories, filter cubes, filters, labware holders, lamps, manifolds, mirrors, miscellaneous, and test plates & reagents. It serves the pharmaceutical and healthcare industries. In October 2018, BioTek released a Peltier Cooling Module for the Cytation Cell Imaging Multi-Mode Readers.
Key Topics Covered
1. Global Newborn Screening Market - Summary
2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Supportive Government Policies in US & Canada
2.2.2. Demand for Newborn Screening Instruments is Rising Steadily
2.2.3. Growth in Dry Blood Spot Test
2.2.4. Techniques Used in Newborn Screening Tests
2.3. Evolution & Transition of Newborn Screening
2.4. Porter's Five Force Analysis
2.4.1. Threat of New Entrants
2.4.2. Threat of Substitute
2.4.3. Bargaining Power of Suppliers
2.4.4. Bargaining Power of Buyers
2.4.5. Threat of Competitive Rivalry
2.5. Key Impact Analysis
2.5.4. Technological Advancement
2.6. Market Attractiveness Index
2.7. Vendor Scorecard
2.8. Industry Components
2.8.1. Raw Material Suppliers
2.9. Regulatory Framework
2.10. Industry Player Positioning
2.11. Key Market Strategies
2.11.1. Product Launch
2.12. Market Drivers
2.12.1. Increase in Occurrences of Newborn Diseases
2.12.2. Growing Number of Infants With Birth Defect
2.12.3. Backing of Government Towards Newborn Child Health
2.12.4. Rising Awareness for Pediatric Congenital Heart Disease
2.13. Market Restraints
2.13.1. Absence of Proper Healthcare Infrastructure for Newborn Babies in Developing Countries
2.13.2. Socio-Economic Hurdles in the Implementation of Newborn Child Screening
2.14. Market Opportunities
2.14.1. Increasing Fertility Rates Across the Globe is Creating Dynamic Growth
2.14.2. Newborn Screening Helps in Early Identification & Management of Affected Newborns
2.14.3. Technological Advancements in Newborn Screening
2.14.4. Increase in Number of Pregnant Women With Advanced Maternal Age
2.15. Market Challenges
2.15.1. Dearth of Skilled Professional in Healthcare Industry
2.15.2. Maintenance of Equipment in Hospital
3. Newborn Screening Market Outlook - By Product
3.1. Newborn Screening Instruments
3.2. Newborn Screening Reagents & Assay Kits
4. Newborn Screening Market Outlook - By Test Type
4.1. Hearing Screen Test
4.2. Critical Congenital Heart Disease (CCHD) Test
4.3. Dry Blood Spot Test
5. Newborn Screening Market Outlook - By Technology
5.1. Tandem Mass Spectrometry
5.2. Pulse Oximetry
5.3. Enzyme-Based Assays
5.4. DNA-Based Assays
6. Newborn Screening Market - Regional Outlook
6.1. North America
6.4. Latin America
6.5. Middle East & Africa
7. Competitive Landscape
7.2. Biotek Instruments Inc.
7.3. Bio-Rad Laboratories Inc.
7.4. Cardinal Health Inc.
7.5. GE Healthcare Limited
7.6. Agilent Technologies Inc.
7.7. Masimo Corporation
7.8. Natus Medical Incorporated
7.9. Medtronic PLC
7.10. Thermo Fisher Scientific Inc.
7.11. Neogen Labs Pvt. Ltd.
7.12. Perkinelmer Inc.
7.13. Zentech S.A.
7.14. Waters Corporation
7.15. Trivitron Healthcare
For more information about this report visit https://www.researchandmarkets.com/r/75qqkh